State of Wisconsin Investment Board’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$949K Buy
45,348
+16,011
+55% +$223K ﹤0.01% 1718
2025
Q4
$260K Buy
+29,337
New +$253K ﹤0.01% 2206
2024
Q4
Sell
-131,508
Closed -$1.01M 2374
2024
Q3
$1.01M Sell
131,508
-6,739
-5% -$64.3K ﹤0.01% 1563
2024
Q2
$1.19M Buy
138,247
+57,115
+70% +$441K ﹤0.01% 1503
2024
Q1
$644K Buy
81,132
+40,773
+101% +$437K ﹤0.01% 1619
2023
Q4
$400K Sell
40,359
-15,735
-28% -$137K ﹤0.01% 1883
2023
Q3
$632K Buy
+56,094
New +$342K ﹤0.01% 1607
2023
Q2
Sell
-43,736
Closed -$173K 2525
2023
Q1
$173K Sell
43,736
-4,908
-10% -$28.5K ﹤0.01% 2300
2022
Q4
$353K Buy
48,644
+10,282
+27% +$72.3K ﹤0.01% 2037
2022
Q3
$139K Sell
38,362
-1,641
-4% -$7.01K ﹤0.01% 2470
2022
Q2
$181K Buy
40,003
+7,403
+23% +$44.8K ﹤0.01% 2522
2022
Q1
$247K Buy
+32,600
New +$283K ﹤0.01% 2133

Other funds holding TNGX

State of Wisconsin Investment Board's TNGX Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Tango Therapeutics (TNGX) stake by 55% in Q1 2026, buying an estimated $223K and bringing the position to 45,348 shares worth $949K. The position accounts for ﹤0.01% of the portfolio, ranked #1718.

State of Wisconsin Investment Board first reported a position in TNGX in Q1 2022 and has held it in 12 quarters since. The position peaked at $1.19M in Q2 2024. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • State of Wisconsin Investment Board held 45,348 shares of Tango Therapeutics worth $949K as of Q1 2026.
  • State of Wisconsin Investment Board bought 16,011 Tango Therapeutics shares in Q1 2026, an estimated $223K.
  • Tango Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1718 holding.
  • State of Wisconsin Investment Board first reported a position in Tango Therapeutics in Q1 2022 and has held it in 12 quarters since.
  • State of Wisconsin Investment Board's Tango Therapeutics position peaked at $1.19M in Q2 2024.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.